Y10S514/913 - CPC Classification Index

#1

20210113458

2021-04-22

SUSTAINED DRUG DELIVERY IMPLANT

#2

20190209467

2019-07-11

SUSTAINED DRUG DELIVERY IMPLANT

#3

20180289618

2018-10-11

Method and composition for treating ocular hypertension and glaucoma

#4

20170112853

2017-04-27

Hypotensive lipid and timolol compositions and methods of using same

#5

20170056399

2017-03-02

Sustained drug delivery implant

#6

20150209351

2015-07-30

Alpha adrenergic receptor modulators

#7

20150150880

2015-06-04

Hypotensive lipid and timolol compositions and methods of using same

#8

20140234390

2014-08-21

Sustained drug delivery implant

#9

20140051704

2014-02-20

Hypotensive lipid and timolol compositions and methods of using same

#10

20140051670

2014-02-20

Compositions containing moxifloxacin for treating otic infections

#11

20120231065

2012-09-13

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

#12

20120208821

2012-08-16

Alpha adrenergic receptor modulators

#13

20120116216

2012-05-10

Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

#14

20120115829

2012-05-10

Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection

#15

20120016001

2012-01-19

Succinimide derivatives as ocular hypotensive agents

#16

20110295034

2011-12-01

Eye drop composition containing isopropyl unoprostone

#17

20110294893

2011-12-01

NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS

#18

20110263638

2011-10-27

Therapeutic agent for glaucoma comprising rho kinase inhibitor and ß- blocker

#19

20110152264

2011-06-23

Method and composition for treating ocular hypertension and glaucoma

#20

20110112066

2011-05-12

Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof

#21

20100075941

2010-03-25

Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof

#22

20100048522

2010-02-25

Method of treating otic infections with moxifloxacin compositions

#23

20090264523

2009-10-22

Method for prevention of degradation of thermally unstable medicament

#24

20090233890

2009-09-17

Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

#25

20090227672

2009-09-10

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

#26

20090181969

2009-07-16

Hypotensive lipid and timolol compositions and methods of using same

#27

20090087481

2009-04-02

Methods of treating neurological conditions with hematopoeitic growth factors

#28

20090029920

2009-01-29

Methods and compositions for treating ocular disorders

#29

20080279814

2008-11-13

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

#30

20080241097

2008-10-02

Methods of treating neurological conditions with hematopoeitic growth factors

#31

20080221184

2008-09-11

Combined agents for treatment of glaucoma

#32

20080181865

2008-07-31

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

#33

20080175894

2008-07-24

Methods of treating neurological conditions with hematopoeitic growth factors

#34

20080171080

2008-07-17

METHODS OF TREATING NEUROLOGICAL CONDITIONS WITH HEMATOPOEITIC GROWTH FACTORS

#35

20080132576

2008-06-05

Methods and compositions for modulating alpha adrenergic receptor activity

#36

20080131484

2008-06-05

Intraocular drug delivery systems

#37

20080075687

2008-03-27

Ophthalmic compositions containing a synergistic combination of three polymers

#38

20070232523

2007-10-04

Therapeutic compositions of oncomodulin

#39

20070231294

2007-10-04

Ophthalmic compositions containing a synergistic combination of three polymers

#40

20070224159

2007-09-27

Ophthalmic compositions containing a synergistic combination of three polymers

#41

20070203174

2007-08-30

Method of treating glaucoma

#42

20070128288

2007-06-07

Ophthalmic compositions containing a synergistic combination of three polymers

#43

20060205709

2006-09-14

Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof

#44

20060142379

2006-06-29

Use of AP-1 activators to treat glaucoma and ocular hypertension

#45

20060094742

2006-05-04

Prostaglandin EPantagonists

#46

20060089361

2006-04-27

Methods for treating retinal diseases

#47

20060069096

2006-03-30

Pyrazolo[3,4-e]benzoxazoles for the treatment of glaucoma

#48

20060052367

2006-03-09

Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker

#49

20050284812

2005-12-29

Process for preparing water soluble diterpenes and their applications

#50

20050250681

2005-11-10

Treatment of ocular diseases and disorders using lantibiotic compositions

#51

20050054558

2005-03-10

Methods and compositions for treating ocular disorders

#52

20050051483

2005-03-10

Process for preparing water soluble diterpenes and their applications

#53

20050043383

2005-02-24

Combined agents for treatment of glaucoma

#54

20050014808

2005-01-20

Combined agents for treatment of glaucoma